Especially, tumors with high DHRS9 immunoexpression (H-scores were above or identical to the median of all scored cases) (Supplementary Figure S1) had a considerably lower grade of tumor regression (p < 0.001). The gene discussed is DHRS9; the disease is neoplasm.